1227270-51-0

Basic information

• Product Name: 1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid
• Synonyms: 1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid;1-(phenylsulfonyl)-6-methyl-7-azaindole-2-carboxylic acid
• CAS NO: 1227270-51-0
• Molecular Formula: C15H12N2O4S
• Molecular Weight: 316.33178
• Mol File: 1227270-51-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid(1227270-51-0)
• EPA Substance Registry System: 1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid(1227270-51-0)

Safety Data

• Hazardous Substances Data: 1227270-51-0(Hazardous Substances Data)

Usage

Description

1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid is a chemical compound derived from azaindole, a heterocyclic compound with potential pharmaceutical applications. It features a phenylsulphonyl group and a carboxylic acid group, which contribute to its potential use in the development of new pharmaceutical agents.

Uses

Used in Pharmaceutical Industry:
1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid is used as a potential sulfonamide drug for its antimicrobial and diuretic properties. The presence of the phenylsulphonyl group allows for the development of drugs that can combat various microbial infections and aid in the regulation of fluid balance in the body.
1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid is also used as a building block for creating new pharmaceutical agents due to its carboxylic acid group. This group can be linked to other molecules, enabling the development of a wide range of drugs with diverse therapeutic applications.
Overall, 1-(Phenylsulphonyl)-6-Methyl-7-azaindole-2-carboxylic acid holds significant potential for further research and development in the pharmaceutical industry, with possible applications in antimicrobial and diuretic drug development, as well as the creation of new pharmaceutical agents through molecular linking.